The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Telmisartan Actavis 20 mg tablets

Actavis Group hfEU/1/10/639/001-010

Main Information

Trade NameTelmisartan Actavis 20 mg tablets
Active SubstancesTelmisartan
Dosage FormTablet
Licence HolderActavis Group hf
Licence NumberEU/1/10/639/001-010

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA07 telmisartan


License statusAuthorised
Licence Issued30/09/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0049-003-014
Interchangeable List DocumentPDF of Interchangeable List
« Back